ICPE Slider

We are heading to Philadelphia for ICPE 2019

August 24 – 28, 2019: Please take a look at the schedule for our department’s oral and poster presentations at the 35th annual International Conference on Pharmacoepidemiology and Therapeutic Risk Management.

carisoprodol study

Study finds moderate reduction in carisoprodol use following DEA Schedule IV classification

UF researchers reviewed more than 13 million patients using carisoprodol, a powerful muscle relaxant.

Haesuk Park headshot

Congratulations to Dr. Haesuk Park on her tenure award and promotion

Park’s tenure and promotion to associate professor became official on July 1.

Medical Marijuana Consortium Slider

Board of Governors selects UF to lead medical marijuana research consortium

As the lead institution, UF will receive $1.5 million in annual recurrent funding from the state of Florida to support the research mission of the Consortium for Medical Marijuana Clinical Outcomes Research.

Asthma - Telehealth Slider

NIH grant will fund study of telehealth for adolescents and young adults with asthma

UF College of Pharmacy researchers will investigate whether telehealth will improve asthma medication adherence and health outcomes.

Quinolones Slider

Popular quinolone ear drops carry risk of eardrum perforation

A new study by University of Florida Health researchers shows quinolone ear drops might cause a perforated eardrum, which can lead to hearing loss.

Prev Next

Welcome to the Department of Pharmaceutical Outcomes and Policy

Thank you for your interest in our department, and our outstanding faculty, students and staff who represent our broad range of programs and resources. Faculty are actively engaged in the entry-level Pharm.D. program and our own graduate program, including one of the nation’s largest Ph.D. programs in pharmaceutical outcomes and policy, a research-focused residential M.S. program and an applied online M.S. program geared toward working professionals.
alt text here

The department’s focus in research and graduate training is centered on the evaluation of drugs and related medical technology. This focus includes classic pharmacoepidemiologic and pharmacoeconomic work, as well as pharmaceutical health services research with a focus on quality and policy involving medication use. Our program has grown tremendously over the past five years with more to come. To find out more, please refer to our annual report and reach out or visit us in beautiful Florida to see one of the nation’s top 10 universities and top 10 pharmacy colleges.

Almut G. Winterstein, Ph.D.
Department Chair

2018 Annual Report

POP Annual Report (Website)(2)

Meet Current POP Students


POP Seminar Announcement: Motomori Lewis

POP Seminar Announcement: Motomori Lewis

Motomori Lewis is a first year PhD student who joined the POP program in Fall 2018.   Motomori received her Bachelors in Public Health and Bachelors in Biomedical Sciences from the […]

POP Seminar Announcement: Xi Wang

POP Seminar Announcement: Xi Wang

Xi Wang received her bachelor’s degree from Xiangya School of Medicine, Central South University, China and her Master of Public Health in epidemiology from Emory University.  Xi’s desires to become […]